Novel imidazolidinones as ns3-serine protease inhibitors of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/38 (2006.01) A61K 31/4166 (2006.01) A61P 31/14 (2006.01) C07K 5/02 (2006.01) C07K 5/04 (2006.01) C07K 7/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2410766

The present invention discloses novel imidazolidinones which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such imidazolidinones as well as methods of using them to treat disorders associated with the HCV protease.

L'invention concerne de nouveaux imidazolidinones présentant une activité inhibitrice de la protéase HCV ainsi que des procédés de fabrication de ces composants. Selon un autre mode de réalisation, des préparations pharmaceutiques contenant lesdits imidazolidinones et des procédés d'utilisation de ces préparations sont proposés en vue de traiter les troubles associés à la protéase HCV.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel imidazolidinones as ns3-serine protease inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel imidazolidinones as ns3-serine protease inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel imidazolidinones as ns3-serine protease inhibitors of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1532370

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.